StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
28
This year
5
Publishing Date
2024 - 03 - 14
1
2024 - 02 - 26
1
2024 - 02 - 12
1
2024 - 01 - 16
2
2023 - 08 - 30
1
2023 - 08 - 02
1
2023 - 06 - 12
1
2023 - 06 - 05
1
2023 - 05 - 09
1
2023 - 04 - 04
1
2022 - 11 - 29
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 19
1
2022 - 09 - 09
1
2022 - 07 - 25
1
2022 - 03 - 01
1
2021 - 12 - 22
1
2021 - 11 - 30
1
2021 - 10 - 25
1
2021 - 10 - 24
1
2021 - 06 - 07
1
2021 - 05 - 24
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 01
1
2020 - 12 - 22
1
Sector
Health technology
28
Tags
Ak006
6
Ak007
1
Atopic dermatitis
1
Biotech-bay
1
Biotechnology
1
Business
2
Cell
4
Clinical trials
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
2
Communications
1
Dermatitis
2
Disease
3
Ema
1
Enroll
1
Expansion
1
Financial
2
Financial results
2
Gastrointestinal
2
Growth
2
Immunology
1
Immunotherapy
1
Ipo
1
Life science
1
Market
2
Meeting
1
Money
2
N/a
20
Offering
1
Pharmaceuticals
1
Phase 2
2
Phase 2/3
2
Phase 3
2
Preclinical
3
Presentation
3
Publication
2
Report
1
Results
4
Study
1
Test
2
Topline
2
Trial
1
Trials
1
Update
2
Urticaria
4
Year
1
Entities
Allakos inc.
28
Aslan pharmaceuticals limited
1
Chinook therapeutics, inc.
1
Equillium, inc.
1
Glaxosmithkline plc
2
Intuitive surgical, inc.
1
Krystal biotech, inc.
1
Mirum pharmaceuticals, inc.
1
Novartis ag
2
Regeneron pharmaceuticals, inc.
1
Sanofi
3
Spruce biosciences, inc.
1
Teva pharmaceutical industries ltd
2
Translate bio, inc.
1
Viatris inc.
2
Symbols
AAPL
1197
ABB
1203
ABBV
608
ABLZF
1165
ABT
1073
ACAQ
522
AMGN
742
AMSIY
465
AMSYF
465
ARCXF
465
ARVL
4293
AVGO
586
AZN
664
BNPQF
1764
BNPQY
1764
CRCW
472
CSCO
897
DNZOF
504
DNZOY
504
ERIC
1611
EXTR
581
FNCTF
7184
FRBA
598
GE
508
GILD
500
GLAXF
657
GOOG
1279
GOOGL
1278
GSK
810
HON
1023
IFNNF
525
IFNNY
503
INTC
955
JNJ
2065
LLY
1087
LTUM
970
MAR
474
MDT
731
MS
1787
MSFT
1200
MT
473
NIPNF
533
NOK
858
NOKBF
974
NVDA
517
NVS
1156
NVSEF
1031
ORCL
787
PCRFF
650
PCRFY
650
PHG
476
PPRUF
1128
PPRUY
1129
SAP
1378
SAPGF
1230
SNY
4534
SNYNF
3592
TEVJF
630
TMO
705
VSAC
533
Exchanges
Nasdaq
28
Nyse
2
Crawled Date
2024 - 03 - 14
1
2024 - 02 - 26
1
2024 - 02 - 12
1
2024 - 01 - 16
2
2023 - 08 - 30
1
2023 - 08 - 02
1
2023 - 06 - 12
1
2023 - 06 - 05
1
2023 - 05 - 09
1
2023 - 04 - 04
1
2022 - 11 - 29
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 19
1
2022 - 09 - 09
1
2022 - 07 - 26
1
2022 - 03 - 01
1
2021 - 12 - 22
1
2021 - 11 - 30
1
2021 - 10 - 25
1
2021 - 10 - 24
1
2021 - 06 - 07
1
2021 - 05 - 24
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 01
1
2020 - 12 - 22
1
Crawled Time
00:00
1
01:00
1
09:00
1
11:00
2
12:00
5
12:20
1
13:00
2
13:03
1
15:00
1
16:00
1
17:00
1
18:00
1
19:00
1
20:00
4
20:20
1
22:00
3
23:00
1
Source
www.biospace.com
8
www.globenewswire.com
18
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
ALLK
exchanges :
Nasdaq
save search
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 20:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-19.54%
|
O:
-1.15%
H:
2.33%
C:
1.55%
business
year
update
financial
results
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
Published:
2024-02-26
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-22.79%
|
O:
2.21%
H:
10.07%
C:
5.04%
ak006
cell
preclinical
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
Published:
2024-02-12
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-21.64%
|
O:
1.49%
H:
10.29%
C:
2.21%
ak006
publication
cell
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
Published:
2024-01-16
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.88%
|
O:
-59.2%
H:
10.66%
C:
-2.46%
urticaria
dermatitis
trials
Allakos Announces a Restructuring to Focus on Development of AK006
Published:
2024-01-16
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.88%
|
O:
-59.2%
H:
10.66%
C:
-2.46%
ak006
Allakos Appoints Neil Graham to its Board of Directors
Published:
2023-08-30
(Crawled : 20:00)
- globenewswire.com
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
7.93%
|
O:
0.11%
H:
0.0%
C:
-1.12%
ASLN
|
$0.539
9.78%
8.91%
300K
|
Health Technology
|
-76.59%
|
O:
1.9%
H:
0.93%
C:
-0.7%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.16%
|
O:
1.02%
H:
5.17%
C:
-2.7%
Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors
Published:
2023-08-02
(Crawled : 20:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-10.05%
|
O:
-1.6%
H:
0.11%
C:
0.11%
TBIO
|
News
|
$0.322
-15.26%
-18.01%
250K
|
Health Technology
|
-70.41%
|
O:
-0.69%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-12.72%
|
O:
-3.79%
H:
0.0%
C:
0.0%
KRYS
|
$164.04
-3.3%
-3.41%
280K
|
Health Technology
|
31.5%
|
O:
-2.31%
H:
0.73%
C:
-1.14%
EQ
|
$1.77
-1.12%
-1.13%
74K
|
Health Technology
|
146.67%
|
O:
9.59%
H:
7.68%
C:
-6.75%
KDNY
|
$40.39
0.22%
-0.17%
0
|
Health Technology
|
0.5%
|
O:
0.02%
H:
0.26%
C:
0.22%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.87%
|
O:
-0.91%
H:
1.84%
C:
-1.1%
Allakos Presents Preclinical Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab and AK006 Mechanisms of Mast Cell Inhibition
Published:
2023-06-12
(Crawled : 11:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-78.13%
|
O:
0.0%
H:
5.21%
C:
2.71%
ak006
cell
preclinical
Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023
Published:
2023-06-05
(Crawled : 11:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.0%
|
O:
0.0%
H:
0.95%
C:
-2.29%
ak006
presentation
cell
immunology
Allakos Provides Business Update and Reports First Quarter 2023 Financial Results
Published:
2023-05-09
(Crawled : 20:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-75.64%
|
O:
0.46%
H:
5.54%
C:
-0.92%
business
update
financial
results
Urticaria Drugs Market size to grow by USD 1.31 billion from 2021 to 2026, Driven by the growth in incidence of urticaria - Technavio
Published:
2023-04-04
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
12.79%
|
O:
1.79%
H:
3.07%
C:
3.07%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-15.15%
|
O:
0.69%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
21.22%
|
O:
1.57%
H:
1.01%
C:
0.96%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
16.68%
|
O:
-0.1%
H:
3.15%
C:
2.94%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-0.43%
|
O:
1.29%
H:
0.83%
C:
0.4%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
8.34%
|
O:
1.2%
H:
1.32%
C:
1.24%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-16.27%
|
O:
1.58%
H:
0.0%
C:
0.0%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-74.88%
|
O:
-0.96%
H:
1.21%
C:
-0.24%
urticaria
growth
market
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
Published:
2022-11-29
(Crawled : 12:20)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-85.73%
|
O:
0.54%
H:
9.19%
C:
7.3%
ak006
communications
publication
Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting
Published:
2022-11-10
(Crawled : 16:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-84.23%
|
O:
3.6%
H:
2.17%
C:
2.17%
ak007
preclinical
immunotherapy
meeting
USD 1.31 Bn growth for Urticaria Drugs Market through 2026: Analysing growth for Pharmaceuticals - Technavio
Published:
2022-09-29
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
33.95%
|
O:
-3.32%
H:
4.73%
C:
4.73%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
22.25%
|
O:
0.22%
H:
0.33%
C:
0.33%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
51.07%
|
O:
1.87%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
27.38%
|
O:
-1.26%
H:
0.7%
C:
-0.23%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
21.96%
|
O:
0.17%
H:
1.1%
C:
0.16%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
34.42%
|
O:
-0.14%
H:
0.53%
C:
-0.2%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
20.43%
|
O:
-0.13%
H:
0.0%
C:
0.0%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-81.8%
|
O:
-2.77%
H:
2.14%
C:
-0.18%
pharmaceuticals
urticaria
growth
market
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
Published:
2022-09-19
(Crawled : 13:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-77.07%
|
O:
16.59%
H:
14.79%
C:
9.36%
offering
Allakos Announces Topline Phase 3 Data from the EoDyssey Study in Patients with Eosinophilic Duodenitis
Published:
2022-09-09
(Crawled : 22:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-77.37%
|
O:
-8.41%
H:
18.12%
C:
15.41%
topline
study
Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors
Published:
2022-07-25
(Crawled : 00:00)
- biospace.com/
ISRG
|
News
|
$372.84
-0.36%
2.53%
2.3M
|
Health Technology
|
75.33%
|
O:
0.64%
H:
4.03%
C:
2.8%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-72.8%
|
O:
-0.26%
H:
0.71%
C:
-4.42%
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-03-01
(Crawled : 23:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.7%
|
O:
-2.02%
H:
7.5%
C:
4.5%
financial results
report
results
Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from the KRYPTOS Study in Patients with Eosinophilic Gastrointestinal Diseases
Published:
2021-12-22
(Crawled : 01:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-98.76%
|
O:
-87.46%
H:
2.55%
C:
-19.19%
phase 2
phase 2/3
gastrointestinal
disease
test
topline
phase 3
Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma
Published:
2021-11-30
(Crawled : 15:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-98.67%
|
O:
-0.92%
H:
0.0%
C:
0.0%
atopic dermatitis
expansion
dermatitis
urticaria
← Previous
1
2
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.